BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) was up 0.3% during trading on Wednesday . The stock traded as high as $3.63 and last traded at $3.53. Approximately 35,112 shares were traded during trading, an increase of 1,789% from the average daily volume of 1,859 shares. The stock had previously closed at $3.52.
BriaCell Therapeutics Stock Up 0.3 %
The stock has a market cap of $2.73 million, a P/E ratio of -0.01 and a beta of 1.09. The business’s 50-day simple moving average is $2.73 and its two-hundred day simple moving average is $1.46.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- Canadian Penny Stocks: Can They Make You Rich?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Are Penny Stocks a Good Fit for Your Portfolio?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
